Tandem Diabetes Care (TNDM) Change in Cash (2013 - 2026)

Tandem Diabetes Care's Change in Cash history runs 14 years deep, the most recent figure standing at $88.7 million for Q1 2026.

• Quarterly Change in Cash rose 666.35% year-over-year to $88.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.8 million (up 2426.57% YoY) and the FY2025 annual result came in at $21.4 million, up 106.44% from the prior year.
• Change in Cash was $88.7 million for Q1 2026 at Tandem Diabetes Care, up from -$1.3 million in the prior quarter.
• Across five years, Change in Cash topped out at $88.7 million in Q1 2026 and bottomed at -$51.1 million in Q3 2023.
• A 5-year average of $6.4 million and a median of $3.0 million in 2023 frame the typical range for Change in Cash.
• Peak annual rise in Change in Cash reached 1974.14% in 2025, while the deepest fall reached 14208.11% in 2025.
• Tandem Diabetes Care's Change in Cash stood at $48.7 million in 2022, then tumbled by 142.57% to -$20.7 million in 2023, then surged by 197.36% to $20.2 million in 2024, then slumped by 106.5% to -$1.3 million in 2025, then soared by 6854.84% to $88.7 million in 2026.
• Business Quant data shows TNDM's Change in Cash at $88.7 million in Q1 2026, -$1.3 million in Q4 2025, and $27.8 million in Q3 2025.